Vaccine candidate offers hope against EBV-associated diseases

The new vaccine candidate offers a breakthrough approach that combines two powerful arms of the immune system to target Epstein–Barr virus in both acute and latent infection.

Related Keywords

Peter Demuth ,Vijayendra Dasari ,Rajiv Khanna ,Nature Communications ,Berghofer Medical Research Institute ,Medical Research Institute ,Professor Rajiv Khanna ,Vaccine ,Epstein Barr Virus ,Gbv ,Qimr Berghofer ,Multiple Sclerosis ,Us ,Atara Biotherapeutics ,